Contribute to the Avicenna Roadmap

Sign up to help create the Avicenna Project’s influential policy document

In order to create the Roadmap for in silico Clinical Trials, the Avicenna project is bringing together experts from healthcare, biomedical research, industry, clinical trials and regulation. 

This collaborative approach is designed to ensure that the Roadmap represents a collegial vision, driven by the needs of industry and wider society to investigate in detail the future steps, the roadblocks, the impact and the research agenda of in silico clinical trials.

The roadmap, which aims to provide a research technology and development strategy that will be used to increase the rate of innovation in healthcare, will be structured in sections that will define Objectives, Philosophy,Roadmap Recommendations section will highlight the scope and the stakeholders of the process, while the section will discuss how ISCT can impact the various phases of development and assessment of a biomedical product. The technological challenges facing future research will emerge from this analysis. These challenges will be represented from the perspective of the producers, the regulators and the providers that will have to translate the research results into products and services for ISCT.

Can you help write the Avicenna Roadmap?

Different levels of participation are foreseen:

  • Author collaborator: willing to help write/rewrite sections of the Roadmap – this will be acknowledged as a co-author of the Roadmap
  • Editor collaborator: willing to help edit sections of the Roadmap – this will be acknowledged as a co-editor of the Roadmap
  • Reviewer collaborator: willing to review and comment on the Roadmap – this will be acknowledged as a co-reviewer of the Roadmap

If you wish to contribute to the authoring process, please contact

Further information on the Avicenna website



Date: 26/11/2014 | Tag: | News: 328 of 1581
All news


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute